Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2018-06-23 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BIOT (06410), Alpes-Maritimes
GRANDE PHARMACIE DE SAINT PHILIPPE : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE SAINT PHILIPPE is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BIOT (06410),
this company of category PME
shows in 2020 a revenue of 919 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE SAINT PHILIPPE (SIREN 842042517)
Indicator
2024
2020
2019
2018
Revenue
N/C
919 423 €
585 007 €
16 600 €
Net income
96 680 €
-58 563 €
-3 212 €
11 699 €
EBITDA
N/C
-34 441 €
29 138 €
13 764 €
Net margin
N/C
-6.4%
-0.5%
70.5%
Revenue and income statement
In 2024, GRANDE PHARMACIE DE SAINT PHILIPPE generates positive net income of 97 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 12 k€ -> 97 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
96 680 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 455%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 15%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
455.006%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
15.448%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE SAINT PHILIPPE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2024
Debt ratio
1361.062
9140.959
43.843
455.006
Financial autonomy
6.591
1.037
67.203
15.448
Repayment capacity
14.192
29.298
-13.089
None
Cash flow / Revenue
70.476%
4.793%
-2.916%
None%
Sector positioning
Debt ratio
455.012024
2019
2020
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of GRANDE PHARMACIE DE SAINT... (455.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
15.45%2024
2019
2020
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of GRANDE PHARMACIE DE SAINT... (15.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
-13.09 years2020
2019
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.3 years
Excellent-50 pts over 2 years
In 2020, the repayment capacity of GRANDE PHARMACIE DE SAINT... (-13.09) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 149.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
148.998
Liquidity indicators evolution GRANDE PHARMACIE DE SAINT PHILIPPE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2024
Liquidity ratio
2703.111
2365.815
2786.264
148.998
Interest coverage
0.0
3.765
-1.341
None
Sector positioning
Liquidity ratio
149.02024
2019
2020
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-41 pts over 3 years
In 2024, the liquidity ratio of GRANDE PHARMACIE DE SAINT... (149.00) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
-1.34x2020
2019
2020
Q1: 0.68x
Med: 3.87x
Q3: 8.37x
Average-15 pts over 2 years
In 2020, the interest coverage of GRANDE PHARMACIE DE SAINT... (-1.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution GRANDE PHARMACIE DE SAINT PHILIPPE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2024
Operating WCR
180 530 €
800 582 €
693 548 €
0 €
Inventory turnover (days)
3396
475
202
0
Customer payment term (days)
90
38
36
0
Supplier payment term (days)
7
1
3
0
Positioning of GRANDE PHARMACIE DE SAINT PHILIPPE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DE SAINT PHILIPPE is estimated at
1 349 724 €
(range 939 926€ - 2 019 264€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
939k€1349k€2019k€
1 349 724 €Range: 939 926€ - 2 019 264€
NAF 5 année 2024
Valuation method used
Net Income Multiple
96 680 €
×
14.0x
=1 349 724 €
Range: 939 927€ - 2 019 265€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE SAINT PHILIPPE with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE SAINT PHILIPPE
What is the revenue of GRANDE PHARMACIE DE SAINT PHILIPPE ?
The revenue of GRANDE PHARMACIE DE SAINT PHILIPPE in 2020 is 919 k€.
Is GRANDE PHARMACIE DE SAINT PHILIPPE profitable?
Yes, GRANDE PHARMACIE DE SAINT PHILIPPE generated a net profit of 97 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DE SAINT PHILIPPE ?
The headquarters of GRANDE PHARMACIE DE SAINT PHILIPPE is located in BIOT (06410), in the department Alpes-Maritimes.
Where to find the tax return of GRANDE PHARMACIE DE SAINT PHILIPPE ?
The tax return of GRANDE PHARMACIE DE SAINT PHILIPPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE SAINT PHILIPPE operate?
GRANDE PHARMACIE DE SAINT PHILIPPE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart